How we differ from Dimensions, GrantForward,
Citeline & PitchBook (bio).
We're not a bibliometrics platform, a trials-analytics suite, or a VC database. We sell the one thing they bury or price out of reach for a sales team: the fresh newly-funded-lab / new-trial GTM trigger, agent-callable, at a fraction of the cost.
✔ Last verified against NIH RePORTER & ClinicalTrials.gov: Jun 21, 2026
The honest table
| Dimension | Dimensions / Digital Science | GrantForward | Citeline / Pharma Intelligence | Research Intelligence (us) |
|---|---|---|---|---|
| Annual price | $10k–$50k+/yr | ~$1k–5k/yr (per institution) | $25k–$100k+/yr | $0 to browse · $300–$5k/mo |
| Primary job | Bibliometrics / research analytics | Grant discovery for academics | Trial & drug-pipeline analytics | Sales GTM triggers (newly-funded buyers) |
| Fresh new-grant trigger (Notice-of-Award dated) | Indexed, lagged | Open RFPs (forward-looking) | Limited grant coverage | Yes — daily, newest-first, source-dated |
| New-trial trigger by sponsor + phase | No | No | Yes — deep | Yes — daily, with sponsor class |
| Cursor delta feed (only what changed) | No | No | Report-style | Yes — whats_changed_since(cursor) |
| Agent-callable (MCP) | No | No | No | Yes — native MCP, five tools |
| Webhook on a watched institution / PI / sponsor | No | Yes — real webhooks per watchlist | ||
| Self-serve, no sales call | No | Mostly | No | Yes — invoice or crypto, key in 1 business day |
| Deep citation graph / author disambiguation | Yes — best-in-class | — | — | No — we are funding & trial events, not bibliometrics |
| Curated drug-pipeline / competitive analytics | — | — | Yes — deep, analyst-curated | No — we are the raw fresh trigger, not the analyst layer |
| Deep historical archive (decades) | Yes | Yes | Yes | Forward-compounding — change-history starts the day you do |
Where they win, we say so. If you need bibliometrics buy Dimensions; if you need curated pipeline analytics buy Citeline; if you're an academic hunting grants buy GrantForward. If you're a sales team that needs to know the day a lab gets funded so you can reach them before competitors, that's us — and we're agent-callable and 1/10th–1/50th the price.
Accuracy & freshness — stated plainly
Source
100% public NIH RePORTER (federal grant record) and ClinicalTrials.gov (federal trial registry). Every row links to its source page. We add nothing we can't cite.
Freshness
Daily snapshot + diff. Grants surface by award-notice date; trials by study-first-posted date. Verified date shown on every page.
Change-history depth
Forward-only today. We started snapshotting recently, so the diff history is shallow now and deepens daily. We never claim a deep archive — that's Dimensions' / Citeline's game, not ours.
Topic tagging
Topics are a transparent keyword model over grant terms / trial conditions — a triage aid, not an ontology. The raw source text and link are always shown so you can verify.
The rest of the life-sciences intelligence stack
Biotech signals (cassandra-bio)
Cross-source biotech signals from grants, trials, and SEC 8-Ks. bio.dropwatchhq.com →
Overdue trial results
FDAAA-801 results-reporting compliance radar — which sponsors are overdue. trials.dropwatchhq.com →
New-funding feed (this product)
The fresh GTM-trigger core. Browse free →